Delivery Order SPE2DR25D1053-SPE2DR26FV246
- Not listed
- The Defense Logistics Agency awarded a $23,009.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for PHESGO 600-600 mg pharmaceutical products (20,000 units of 10ml vials), with an ultimate completion date of January 21, 2026. This non-set-aside delivery order was competitively awarded on December 29, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $17,256.90 to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of PHESGO 600-600 MG pharmaceutical product in 10ML units (20,000 units total). This is a firm fixed-price delivery order with an ultimate completion date of December 29, 2025, and represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $1.37 million by the Defense Logistics Agency's Medical Supply Chain with an ultimate completion date of December 12, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $551,900.70 by the Defense Logistics Agency's Medical Supply Chain, with an ultimate completion date of November 12, 2025. This competitive, non-set-aside delivery order utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed price delivery order valued at $11,879.83 by the Defense Logistics Agency's Medical Supply Chain on January 5, 2026, with an ultimate completion date of January 6, 2026. This non-competitive, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical, designated SPE2DX, which carries a potential...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $424,539 by the Defense Logistics Agency's Medical Supply Chain on October 6, 2025, with an ultimate completion date of October 7, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $173,863.80 by the Defense Logistics Agency's Medical Supply Chain on September 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by September 24, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $49,176.08 by the Defense Logistics Agency's Medical Supply Chain on September 22, 2025. The contract is a firm fixed-price delivery order with a completion date of September 23, 2025, and represents a non-set-aside competitive award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $56,288.18 by the Defense Logistics Agency's Medical Supply Chain on May 30, 2025. The contract, with an ultimate completion date of June 2, 2025, represents a non-set-aside, competitively awarded procurement. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $872,827.10 by the Defense Logistics Agency's Medical Supply Chain on October 30, 2025. This is a non-set-aside, competitively awarded contract with firm fixed price terms and an ultimate completion date of October 31, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FV246Delivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $11,261.28 firm fixed-price delivery order by the Defense Logistics Agency on January 5, 2026, for PHESGO 600-600 mg pharmaceutical product (20,000 units of 10ml vials). This is a non-set-aside contract with an ultimate completion date of January 27, 2026. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications and medical supplies to support military healthcare programs worldwide. The Defense Logistics Agency, a combat support agency under the Department of Defense, procures and distributes critical pharmaceutical products and medical supplies to support military health systems, the Defense Health Agency, and other federal healthcare entities. AmerisourceBergen's SPE2DX contract represents its position as a primary vendor within DLA's pharmaceutical supply chain, with demonstrated capability to fulfill federal medical procurement requirements through open competition. The DLA has indicated plans to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, potentially involving additional contractors alongside AmerisourceBergen.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.3k | 1/4/26 |